| LCMGX | VEXRX | LCMGX / VEXRX | |
| Total Expense Ratio | 2.13 | 0.33 | 645% |
| Annual Report Gross Expense Ratio | 2.13 | 0.33 | 645% |
| Fund Existence | 5 years | 24 years | - |
| Gain YTD | 9.108 | 4.764 | 191% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1500 | 50000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 199M | 20.6B | 1% |
| Annual Yield % from dividends | 0.00 | 0.49 | - |
| Returns for 1 year | 13.74 | -3.21 | -429% |
| Returns for 3 years | 44.51 | 25.94 | 172% |
| Returns for 5 years | 1.11 | 3.55 | 31% |
| Returns for 10 years | N/A | 34.47 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PHYL | 35.50 | 0.03 | +0.10% |
| PGIM Active High Yield Bond ETF | |||
| EMMF | 31.00 | 0.03 | +0.09% |
| WisdomTree Emerging Markets Mltfctr | |||
| FPAS | 25.45 | N/A | N/A |
| FPA Short Duration Government ETF | |||
| CGXU | 30.10 | -0.10 | -0.33% |
| Capital Group International Focus Eq ETF | |||
| HELX | 33.14 | -0.25 | -0.76% |
| Franklin Genomic Advancements ETF | |||